Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;80(2):346-354.
doi: 10.1007/s12020-022-03270-x. Epub 2022 Dec 3.

Assessment of the reporting quality of randomised controlled trials for vitamin D supplementation in autoimmune thyroid disorders based on the CONSORT statement

Christos Vrysis  1 , Eirini Beneki  2 , Elias Zintzaras  1   3   4 , Chrysoula Doxani  1
Affiliations

Assessment of the reporting quality of randomised controlled trials for vitamin D supplementation in autoimmune thyroid disorders based on the CONSORT statement

Christos Vrysis et al. Endocrine. 2023 May.

Erratum in

Abstract

Background-purpose: Randomized controlled trials (RCTs) are the cornerstone of evidence-based medicine, yet their quality is often suboptimal. The Consolidated Standards of Reporting Trials (CONSORT) statement is a list of advice to upgrade the quality of RCTs. The aim of this study was the assessment of the quality of RCTs for vitamin D supplements in thyroid autoimmunity according to the revised CONSORT 2010 checklist.

Methods: Databases were searched for RCTs involving patients with autoimmune thyroid disorders (AITDs) who received vitamin D supplements published from 2011 to 2021. A list of 37-items was used and adherence ≥75% was considered of optimal quality. The primary outcome was the mean CONSORT adherence of studies. Secondary outcomes were the estimation of compliance per CONSORT item and the examination for possible determinants of the reporting quality.

Results: Thirteen eligible trials were finally included. The mean compliance was 61.15% ± 14.86%. Only threeof the studies (23%) achieved a good reporting quality (≥75%), while ten (77%) were presented with inadequate reporting (<75%). Randomization and blinding were mainly poorly reported. Impact Factor (IF) of journal was associated with the reporting quality in the univariate analysis [p = 0.033, OR = 1.65, 95%CI = (1316, 1773)]. Sample size (p = 0.067), number of authors (p = 0.118) and number of citations (p = 0.125) were marginally not significant. None of the factors showed significant results in multivariate analysis. Reporting quality and IF were strongly positively correlated [Pearson's r = 0.740, p = 0.04].

Conclusion: This study shows that mean CONSORT adherence of RCTs for Vitamin D supplementation in AITDs is moderate, reflecting that study quality and transparency could be improved with better adherence to CONSORT rules.

Keywords: Autoimmune thyroid disease; CONSORT; Graves’ disease; Hashimoto disease; Randomized controlled trials; Vitamin D supplementation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow diagram
Fig. 2
Fig. 2
Distribution of the total CONSORT (Consolidated Standards of Reporting Trials) scores of the 13 studies
Fig. 3
Fig. 3
Correlation (scatter-plot) between reporting quality and IF (Impact Factor)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. McLeod DSA, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252–265. doi: 10.1007/s12020-012-9703-2. - DOI - PubMed
    1. Zhao R, Zhang W, Ma C, Zhao Y, Xiong R, Wang H, et al. Immunomodulatory function of vitamin D and its role in autoimmune thyroid disease. Front. Immunol. 2021;12:574967. doi: 10.3389/fimmu.2021.574967. - DOI - PMC - PubMed
    1. Mele C, Caputo M, Bisceglia A, Samà MT, Zavattaro M, Aimaretti G, et al. Immunomodulatory effects of vitamin D in thyroid diseases. Nutrients. 2020;12(5):1444. doi: 10.3390/nu12051444. - DOI - PMC - PubMed
    1. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 2000;223(3):230–233. doi: 10.1046/j.1525-1373.2000.22333.x. - DOI - PubMed
    1. Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann. Nutr. Metab. 2018;72(2):87–95. doi: 10.1159/000486536. - DOI - PubMed

LinkOut - more resources

-